Amicus Therapeutics (NASDAQ:FOLD) Given “Equal Weight” Rating at Morgan Stanley
Amicus Therapeutics (NASDAQ:FOLD – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Morgan Stanley in a report released on Friday,Benzinga reports. They currently have a $12.00 target price on the biopharmaceutical company’s stock, down from their prior target price of $17.00. Morgan Stanley’s target price indicates a potential upside […]
More Stories
Invesco FTSE RAFI US 1000 ETF (NYSEARCA:PRF) Sees Large Volume Increase – Here’s Why
Invesco FTSE RAFI US 1000 ETF (NYSEARCA:PRF – Get Free Report) shares saw unusually-strong trading volume on Wednesday . Approximately...
Tidewater Midstream and Infrastructure (TSE:TWM) Hits New 12-Month Low – Should You Sell?
Tidewater Midstream and Infrastructure Ltd. (TSE:TWM – Get Free Report) shares hit a new 52-week low during trading on Friday...
Holcim AG (OTCMKTS:HCMLY) Sees Large Increase in Short Interest
Holcim AG (OTCMKTS:HCMLY – Get Free Report) was the target of a large growth in short interest in November. As...
VanEck Digital Transformation ETF (NASDAQ:DAPP) Short Interest Up 238.6% in November
VanEck Digital Transformation ETF (NASDAQ:DAPP – Get Free Report) saw a significant increase in short interest in the month of...
PureTech Health (NASDAQ:PRTC) Shares Gap Down – Here’s What Happened
PureTech Health plc (NASDAQ:PRTC – Get Free Report)’s stock price gapped down before the market opened on Wednesday . The...
GCM Resources (LON:GCM) Stock Price Down 11.8% – Here’s Why
GCM Resources Plc (LON:GCM – Get Free Report)’s share price fell 11.8% during mid-day trading on Wednesday . The stock...